search
Back to results

Digital Therapeutic for Chronic Pain Feasibility Study

Primary Purpose

Chronic Pain

Status
Recruiting
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
2Morrow Chronic Pain Self-Management Program - digital therapeutic mobile app
Treatment as usual
Sponsored by
University of Washington
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Pain focused on measuring chronic pain, primary care, digital therapeutic, mobile app, pain function, pain interference, psychotherapy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: >=18 years old at least one ICD pain related diagnosis noted in the electronic health record (EHR) at least 2 visits in a primary care clinic with at least one in the last 12 months willing to use a mobile app in English T-score for the PROMIS brief pain inventory of >= 55 access to a smartphone willing to download and use a mobile app daily Exclusion Criteria: current cancer related diagnosis (to exclude cancer related chronic pain) plans for surgery in next 3 months pregnant currently receiving hospice care

Sites / Locations

  • University of Washington Primary CareRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Treatment as usual

Intervention arm

Arm Description

Treatment as usual arm entails the patients continuing to receive care from their primary care provider and any specialists they choose to get involved in their care.

Intervention arm includes access to the digital therapeutic mobile app in addition to treatment as usual

Outcomes

Primary Outcome Measures

PROMIS Pain Interference Scale - Short Form 6b
Brief survey of patient's perceived pain interference in their ability to function; scores are normed on a T-score with 50 as the mean, 10 as the standard deviation, and higher scores are worse

Secondary Outcome Measures

Patient Health Questionnaire 9 (PHQ-9)
depression symptom measure; scores range from 0 to 27; higher scores are worse
Generalized Anxiety Disorder 7 (GAD-7)
anxiety symptom measure; scores range from 0-21; higher scores are worse

Full Information

First Posted
August 10, 2023
Last Updated
September 12, 2023
Sponsor
University of Washington
Collaborators
National Center for Complementary and Integrative Health (NCCIH)
search

1. Study Identification

Unique Protocol Identification Number
NCT06000007
Brief Title
Digital Therapeutic for Chronic Pain Feasibility Study
Official Title
Development and Implementation of a Behavioral Digital Therapeutic Designed to Support, Educate, Screen and Remotely Monitor Patients With Chronic Pain
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
August 25, 2023 (Actual)
Primary Completion Date
May 31, 2024 (Anticipated)
Study Completion Date
May 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Washington
Collaborators
National Center for Complementary and Integrative Health (NCCIH)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The investigators will conduct a 2-arm randomized control feasibility study to evaluate: 1) the feasibility of using the mobile app and an optional activity tracker, 2) the feasibility of conducting a 2-arm trial, and 3) estimate the effect size for planning for a larger efficacy trial based on our primary outcomes. The intervention arm will test a mobile app that aims to help people reduce pain interference who have chronic pain, as well as mental health issues with depression and anxiety. Participants in the intervention arm will also have the option to sense health data with a tracker that integrates with the app, which will inform the feasibility of this feature.
Detailed Description
This study will evaluate the existing 2Morrow Chronic Pain Self-Management Program, in the form of a mobile app, as a digital therapeutic for improving patients' pain self management and function who suffer from chronic pain. Specifically, the investigators will conduct a 2-arm randomized control feasibility study to evaluate: 1) the feasibility of using the mobile app and an optional activity tracker, 2) the feasibility of conducting a 2-arm trial, and 3) estimate the effect size for planning for a larger efficacy trial based on our primary outcomes. The intervention arm will test a mobile app that aims to help people reduce pain interference who have chronic pain, as well as mental health issues with depression and anxiety. Participants in the intervention arm will also have the option to sense health data with a tracker that integrates with the app, which will inform the feasibility of this feature.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Pain
Keywords
chronic pain, primary care, digital therapeutic, mobile app, pain function, pain interference, psychotherapy

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Model Description
Randomized control feasibility study with two arms: intervention arm vs. control arm
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Treatment as usual
Arm Type
Active Comparator
Arm Description
Treatment as usual arm entails the patients continuing to receive care from their primary care provider and any specialists they choose to get involved in their care.
Arm Title
Intervention arm
Arm Type
Active Comparator
Arm Description
Intervention arm includes access to the digital therapeutic mobile app in addition to treatment as usual
Intervention Type
Device
Intervention Name(s)
2Morrow Chronic Pain Self-Management Program - digital therapeutic mobile app
Intervention Description
2Morrow Chronic Pain Self-Management Program is delivered via a mobile app that engaged patients in evidenced based psychotherapy for chronic pain, including Acceptance and Commitment Therapy and Cognitive Behavioral Therapy based activities, to improve a patient's pain self management. The mobile app also offers the ability to track activities, screen for other problems, support for communicating with medical providers, and access a coach via texting.
Intervention Type
Other
Intervention Name(s)
Treatment as usual
Intervention Description
Treatment as usual entails continuing with treatment for chronic pain with the patient's primary care provider and any potential specialists they choose to engage with.
Primary Outcome Measure Information:
Title
PROMIS Pain Interference Scale - Short Form 6b
Description
Brief survey of patient's perceived pain interference in their ability to function; scores are normed on a T-score with 50 as the mean, 10 as the standard deviation, and higher scores are worse
Time Frame
will be measured at baseline, 1 month, 3 months, and 6 months after enrollment (and start of intervention in the intervention arm)
Secondary Outcome Measure Information:
Title
Patient Health Questionnaire 9 (PHQ-9)
Description
depression symptom measure; scores range from 0 to 27; higher scores are worse
Time Frame
will be measured at baseline, 1 month, 3 months, and 6 months after enrollment (and start of intervention in the intervention arm)
Title
Generalized Anxiety Disorder 7 (GAD-7)
Description
anxiety symptom measure; scores range from 0-21; higher scores are worse
Time Frame
will be measured at baseline, 1 month, 3 months, and 6 months after enrollment (and start of intervention in the intervention arm)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: >=18 years old at least one ICD pain related diagnosis noted in the electronic health record (EHR) at least 2 visits in a primary care clinic with at least one in the last 12 months willing to use a mobile app in English T-score for the PROMIS brief pain inventory of >= 55 access to a smartphone willing to download and use a mobile app daily Exclusion Criteria: current cancer related diagnosis (to exclude cancer related chronic pain) plans for surgery in next 3 months pregnant currently receiving hospice care
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Brennan Keiser, MSW
Phone
206-221-7863
Email
bkeiser@uw.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kari A Stephens, Ph.D.
Organizational Affiliation
University of Washington
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Washington Primary Care
City
Seattle
State/Province
Washington
ZIP/Postal Code
98116
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kari A Stephens, PhD
Phone
206-221-0349
Email
kstephen@uw.edu

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Data will be made upon request after evaluation for appropriateness by principal investigator as an appropriate research request by individuals seeking to do further research. All data will be de-identified to protect participant privacy.
IPD Sharing Time Frame
Sharing will occur after the publication of the final outcomes of the study are published and will be available for up to 7 years post completion of data collection.
IPD Sharing Access Criteria
The requestor must provide acceptable research justification and appropriate permissions from their institutional to use the data requested for specific and detailed research purposes.

Learn more about this trial

Digital Therapeutic for Chronic Pain Feasibility Study

We'll reach out to this number within 24 hrs